Cargando…

Correction: Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy

Detalles Bibliográficos
Autores principales: Gritt, Giuseppe, Gianatt, Andrea, Petronzeii, Fiorella, De Santis, Rita, Pavoni, Chiara, Rossi, Riccardo Lorenzo, Cattaneo, Laura, Spagnoli, Luigi Giusto, Ferrar, Silvia, Ross, Andrea, Barbu, Anna Maria, Rambald, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908322/
https://www.ncbi.nlm.nih.gov/pubmed/29683132
http://dx.doi.org/10.18632/oncotarget.25064
_version_ 1783315701865381888
author Gritt, Giuseppe
Gianatt, Andrea
Petronzeii, Fiorella
De Santis, Rita
Pavoni, Chiara
Rossi, Riccardo Lorenzo
Cattaneo, Laura
Spagnoli, Luigi Giusto
Ferrar, Silvia
Ross, Andrea
Barbu, Anna Maria
Rambald, Alessandro
author_facet Gritt, Giuseppe
Gianatt, Andrea
Petronzeii, Fiorella
De Santis, Rita
Pavoni, Chiara
Rossi, Riccardo Lorenzo
Cattaneo, Laura
Spagnoli, Luigi Giusto
Ferrar, Silvia
Ross, Andrea
Barbu, Anna Maria
Rambald, Alessandro
author_sort Gritt, Giuseppe
collection PubMed
description
format Online
Article
Text
id pubmed-5908322
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-59083222018-04-20 Correction: Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy Gritt, Giuseppe Gianatt, Andrea Petronzeii, Fiorella De Santis, Rita Pavoni, Chiara Rossi, Riccardo Lorenzo Cattaneo, Laura Spagnoli, Luigi Giusto Ferrar, Silvia Ross, Andrea Barbu, Anna Maria Rambald, Alessandro Oncotarget Correction Impact Journals LLC 2018-03-30 /pmc/articles/PMC5908322/ /pubmed/29683132 http://dx.doi.org/10.18632/oncotarget.25064 Text en Copyright: © 2018 Gritti et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Correction
Gritt, Giuseppe
Gianatt, Andrea
Petronzeii, Fiorella
De Santis, Rita
Pavoni, Chiara
Rossi, Riccardo Lorenzo
Cattaneo, Laura
Spagnoli, Luigi Giusto
Ferrar, Silvia
Ross, Andrea
Barbu, Anna Maria
Rambald, Alessandro
Correction: Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy
title Correction: Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy
title_full Correction: Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy
title_fullStr Correction: Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy
title_full_unstemmed Correction: Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy
title_short Correction: Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy
title_sort correction: evaluation of tenascin-c by tenatumomab in t-cell non-hodgkin lymphomas identifies a new target for radioimmunotherapy
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908322/
https://www.ncbi.nlm.nih.gov/pubmed/29683132
http://dx.doi.org/10.18632/oncotarget.25064
work_keys_str_mv AT grittgiuseppe correctionevaluationoftenascincbytenatumomabintcellnonhodgkinlymphomasidentifiesanewtargetforradioimmunotherapy
AT gianattandrea correctionevaluationoftenascincbytenatumomabintcellnonhodgkinlymphomasidentifiesanewtargetforradioimmunotherapy
AT petronzeiifiorella correctionevaluationoftenascincbytenatumomabintcellnonhodgkinlymphomasidentifiesanewtargetforradioimmunotherapy
AT desantisrita correctionevaluationoftenascincbytenatumomabintcellnonhodgkinlymphomasidentifiesanewtargetforradioimmunotherapy
AT pavonichiara correctionevaluationoftenascincbytenatumomabintcellnonhodgkinlymphomasidentifiesanewtargetforradioimmunotherapy
AT rossiriccardolorenzo correctionevaluationoftenascincbytenatumomabintcellnonhodgkinlymphomasidentifiesanewtargetforradioimmunotherapy
AT cattaneolaura correctionevaluationoftenascincbytenatumomabintcellnonhodgkinlymphomasidentifiesanewtargetforradioimmunotherapy
AT spagnoliluigigiusto correctionevaluationoftenascincbytenatumomabintcellnonhodgkinlymphomasidentifiesanewtargetforradioimmunotherapy
AT ferrarsilvia correctionevaluationoftenascincbytenatumomabintcellnonhodgkinlymphomasidentifiesanewtargetforradioimmunotherapy
AT rossandrea correctionevaluationoftenascincbytenatumomabintcellnonhodgkinlymphomasidentifiesanewtargetforradioimmunotherapy
AT barbuannamaria correctionevaluationoftenascincbytenatumomabintcellnonhodgkinlymphomasidentifiesanewtargetforradioimmunotherapy
AT rambaldalessandro correctionevaluationoftenascincbytenatumomabintcellnonhodgkinlymphomasidentifiesanewtargetforradioimmunotherapy